Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences

• Main Authors: Bernardo Rossini (Author), Nicola Cecchi (Author), Felice Clemente (Author), Maria Rosaria De Paolis (Author), Stefan Hohaus (Author), Vanessa Innao (Author), Mariano Lucignano (Author), Roberto Massaiu (Author), Giovanna Palumbo (Author), Gian Matteo Rigolin (Author), Francesca Gaia Rossi (Author), Luisa Verga (Author), Attilio Guarini (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Castleman disease (CD) is a group of lymphoproliferative disorders that share common histopathological features yet have widely different aetiologies, clinical features and grades of severity as well as treatments and outcomes. Siltuximab is currently the only therapy approved by the FDA and EMA for...